Ethics in the digital workplace
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
On 2 September 2014, the Danish pharmaceuticals multinational Novo Nordisk announced that it intended to discontinue all its research and development (R&D) activities within its inflammatory disorders division, affecting a total of 400 jobs in Denmark, China and the USA. In the USA, it will close its inflammation research centre in Seattle, with the loss of 63 jobs.
Novo Nordisk currently estimates that it will be possible to offer other positions within the company to more than half of the 400 affected employees. The company has initiated negotiations with the relevant local unions regarding redundancy plans.
Eurofound (2014), Novo Nordisk, Internal restructuring in World, factsheet number 77845, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/77845.